# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(...
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...
-SEC Filing